⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

June 10, 2024Journal of Liver CancerOpen Access

Assessment of Real-Time US-CT/MR-guided Percutaneous Gold Fiducial Marker Implementation in Malignant Hepatic Tumors for Stereotactic Body Radiation Therapy

Sungjun Hwang Seok-Joo Chun Eui Kyu Chie Jeong Min Lee

View Full Paper

Ask AI

Bookmark

Share

Abstract

This study explored the initial institutional experience of using gold fiducial markers for stereotactic body radiotherapy (SBRT) in treating malignant hepatic tumors using real-time ultrasound-computed tomography (CT)/magnetic resonance (MR) imaging fusion-guided percutaneous placement.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Hwang et al. (2024) studied this question.

synapsesocial.com/papers/68e6567bb6db6435875e5a8f https://doi.org/10.17998/jlc.2024.06.03

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Targeting the invisible: precision fiducial marker placement in poorly visible liver tumors prior to percutaneous ablation using real-time image fusion guidance2025
2Radiomic feature robustness in CT scans affected by fiducial marker induced streak artifacts for patients with hepatocellular carcinoma2024
3Cardiac embolization of an implanted fiducial marker for hepatic stereotactic body radiotherapy: a case reportCase Report · 2009 · 29 citations
4Feasibility of using a single MRI acquisition for fiducial marker localization and synthetic CT generation towards MRI-only prostate radiation therapy treatment planning2024
5Single-Center Preliminary Experience Treating Endometrial Cancer Patients with Fiducial Markers2025 · 1 citations